Development of Dog Vaccination Strategies to Maintain Herd Immunity against Rabies.
decentralized continuous vaccination
herd immunity
mass dog vaccination
rabies
vaccination strategy
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
16 04 2022
16 04 2022
Historique:
received:
28
02
2022
revised:
14
03
2022
accepted:
19
03
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
27
4
2022
Statut:
epublish
Résumé
Human rabies can be prevented through mass dog vaccination campaigns; however, in rabies endemic countries, pulsed central point campaigns do not always achieve the recommended coverage of 70%. This study describes the development of a novel approach to sustain high coverage based on decentralized and continuous vaccination delivery. A rabies vaccination campaign was conducted across 12 wards in the Mara region, Tanzania to test this approach. Household surveys were used to obtain data on vaccination coverage as well as factors influencing dog vaccination. A total 17,571 dogs were vaccinated, 2654 using routine central point delivery and 14,917 dogs using one of three strategies of decentralized continuous vaccination. One month after the first vaccination campaign, coverage in areas receiving decentralized vaccinations was higher (64.1, 95% Confidence Intervals (CIs) 62.1-66%) than in areas receiving pulsed vaccinations (35.9%, 95% CIs 32.6-39.5%). Follow-up surveys 10 months later showed that vaccination coverage in areas receiving decentralized vaccinations remained on average over 60% (60.7%, 95% CIs 58.5-62.8%) and much higher than in villages receiving pulsed vaccinations where coverage was on average 32.1% (95% CIs 28.8-35.6%). We conclude that decentralized continuous dog vaccination strategies have the potential to improve vaccination coverage and maintain herd immunity against rabies.
Identifiants
pubmed: 35458560
pii: v14040830
doi: 10.3390/v14040830
pmc: PMC9028497
pii:
doi:
Substances chimiques
Rabies Vaccines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Wellcome Trust
ID : 207569/Z/17/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI141712
Pays : United States
Organisme : NIH HHS
ID : R01AI141712
Pays : United States
Organisme : Wellcome Trust
ID : 107753/A/15/Z & 207569/Z/17/Z
Pays : United Kingdom
Références
Antiviral Res. 2013 May;98(2):314-8
pubmed: 23499647
PLoS Negl Trop Dis. 2015 Feb 03;9(2):e0003447
pubmed: 25646774
Epidemiol Infect. 2009 Nov;137(11):1558-67
pubmed: 19327197
Zoonoses Public Health. 2011 Mar;58(2):110-8
pubmed: 20042063
Vaccine. 2018 Apr 19;36(17):2321-2325
pubmed: 29580642
Vaccine. 2017 Apr 19;35(17):2214-2216
pubmed: 28364934
Vaccine. 2016 Feb 10;34(7):899-904
pubmed: 26778422
Vet Rec. 2014 Aug 30;175(8):188-93
pubmed: 25172649
PLoS Negl Trop Dis. 2021 Apr 28;15(4):e0009222
pubmed: 33909621
BMC Infect Dis. 2019 Nov 20;19(1):977
pubmed: 31747889
PLoS Negl Trop Dis. 2016 Jul 14;10(7):e0004824
pubmed: 27414810
PLoS Negl Trop Dis. 2017 Mar 17;11(3):e0005460
pubmed: 28306717
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14996-5001
pubmed: 19706492
Front Vet Sci. 2017 Jul 10;4:109
pubmed: 28740850
Epidemiol Infect. 2002 Aug;129(1):215-22
pubmed: 12211590
Vaccine. 2012 May 21;30(24):3492-502
pubmed: 22480924
Front Vet Sci. 2017 Jan 09;3:123
pubmed: 28119919
Vaccine. 1996 Feb;14(3):185-6
pubmed: 8920697
Prev Vet Med. 2009 Aug 1;90(3-4):153-9
pubmed: 19482366
Prev Vet Med. 2016 Aug 1;130:67-76
pubmed: 27435648
PLoS Negl Trop Dis. 2013 Aug 22;7(8):e2372
pubmed: 23991233
Front Vet Sci. 2017 Feb 10;4:9
pubmed: 28239608
PLoS One. 2016 Nov 28;11(11):e0167092
pubmed: 27893866
Bull World Health Organ. 2003;81(10):739-44
pubmed: 14758434
Vet Rec. 2000 Oct 14;147(16):442-6
pubmed: 11079440
Transbound Emerg Dis. 2020 Nov;67(6):2679-2691
pubmed: 32438530
Comp Immunol Microbiol Infect Dis. 1982;5(1-3):265-70
pubmed: 7128081
Trop Med Infect Dis. 2020 Aug 11;5(3):
pubmed: 32796605
Bull World Health Organ. 2005 May;83(5):360-8
pubmed: 15976877
PLoS One. 2018 Jul 26;13(7):e0200942
pubmed: 30048469
Vaccine. 2016 Jan 20;34(4):571-577
pubmed: 26631415
PLoS Negl Trop Dis. 2010 Feb 23;4(2):e626
pubmed: 20186330
PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0005946
pubmed: 28991898
J R Soc Interface. 2017 Sep;14(134):
pubmed: 28904005
Vaccine. 2018 Jan 25;36(4):553-558
pubmed: 29248264
PLoS Negl Trop Dis. 2015 Nov 06;9(11):e0004177
pubmed: 26545242
Curr Opin Virol. 2012 Jun;2(3):309-14
pubmed: 22503445
PLoS Biol. 2009 Mar 10;7(3):e53
pubmed: 19278295
PLoS Negl Trop Dis. 2014 Nov 13;8(11):e3160
pubmed: 25393023
J Appl Ecol. 2014 Aug;51(4):1096-1106
pubmed: 25657481
Prev Vet Med. 2015 Jun 15;120(2):203-209
pubmed: 25953653
BMC Vet Res. 2012 Dec 05;8:236
pubmed: 23217194
Lancet. 2014 Oct 11;384(9951):1389-99
pubmed: 24828901
Vaccine. 2003 May 16;21(17-18):1965-73
pubmed: 12706685
Vet J. 2019 Jul;249:60-66
pubmed: 31239167
Vaccine. 2016 Nov 4;34(46):5504-5511
pubmed: 27729174
PLoS Negl Trop Dis. 2020 Jan 23;14(1):e0008004
pubmed: 31971943
PLoS Negl Trop Dis. 2018 Jan 11;12(1):e0006159
pubmed: 29324737
Vaccine. 2009 Jan 1;27(1):152-60
pubmed: 18848595
PLoS Negl Trop Dis. 2015 Dec 03;9(12):e0004221
pubmed: 26633821